HUM vs IBTA · P/E 39, rev $117.76B vs rev $367.3M
Humana Inc (HUM) versus Ibotta, Inc. (IBTA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Ibotta, Inc. (IBTA) is a software - application company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IBTA revenue for 2024-12-31 was $367.3M. Net income was $68.7M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. IBTA currently screens at market cap $764.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IBTA currently screens at market cap $764.6M.
Not investment advice. Open the HUM and IBTA stock pages for the full models.
Not investment advice.